{"id":"https://openalex.org/W7220855780","doi":"https://doi.org/10.3389/fonc.2026.1856673","title":"A surprising complete radiographic response to palbociclib plus endocrine therapy in an HR-positive, HER2-low lung, pleural, and lymph node metastatic breast cancer patient: a case report","display_name":"A surprising complete radiographic response to palbociclib plus endocrine therapy in an HR-positive, HER2-low lung, pleural, and lymph node metastatic breast cancer patient: a case report","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220855780","doi":"https://doi.org/10.3389/fonc.2026.1856673","pmid":"https://pubmed.ncbi.nlm.nih.gov/42908516","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13682961"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1856673","doi":"https://doi.org/10.3389/fonc.2026.1856673","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1856673","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1856673/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1856673/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157821482","display_name":"Mingzhi Cha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121805","display_name":"Jiangxi Pingxiang People's Hospital","ror":"https://ror.org/02qkhx131","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121805"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingzhi Cha","raw_affiliation_strings":["Department of Breast Surgery, Pingxiang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Pingxiang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210121805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111178278","display_name":"Hao Yi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121805","display_name":"Jiangxi Pingxiang People's Hospital","ror":"https://ror.org/02qkhx131","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121805"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hao Yi","raw_affiliation_strings":["Department of Breast Surgery, Pingxiang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Pingxiang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210121805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157851635","display_name":"HuiMing Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121805","display_name":"Jiangxi Pingxiang People's Hospital","ror":"https://ror.org/02qkhx131","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121805"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"HuiMing Li","raw_affiliation_strings":["Department of Pathology, Pingxiang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Pingxiang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210121805"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053232831","display_name":"Rongrong Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121805","display_name":"Jiangxi Pingxiang People's Hospital","ror":"https://ror.org/02qkhx131","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121805"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Rongrong Peng","raw_affiliation_strings":["Department of Breast Surgery, Pingxiang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Pingxiang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210121805"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053232831"],"corresponding_institution_ids":["https://openalex.org/I4210121805"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.72821983,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1856673","last_page":"1856673"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.8579999804496765},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.875},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.902999997138977},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9129999876022339},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9210000038146973},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.7080000042915344},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.859000027179718},{"id":"https://openalex.org/keywords/pleural-metastasis","display_name":"pleural metastasis","score":0.9760000109672546},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.921999990940094},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9226999878883362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067000150680542},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.8173999786376953},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.795799970626831},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6478000283241272},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.6416000127792358},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.57669997215271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5667999982833862},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.513700008392334},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.4702000021934509},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.3903000056743622},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36329999566078186},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.32690000534057617},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.3221000134944916},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.3208000063896179},{"id":"https://openalex.org/C2776608951","wikidata":"https://www.wikidata.org/wiki/Q499","display_name":"Axilla","level":4,"score":0.30480000376701355},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.30309998989105225},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.29179999232292175},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.28110000491142273},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.2800999879837036},{"id":"https://openalex.org/C2777649267","wikidata":"https://www.wikidata.org/wiki/Q340695","display_name":"Axillary lymph nodes","level":4,"score":0.2671999931335449},{"id":"https://openalex.org/C2779720271","wikidata":"https://www.wikidata.org/wiki/Q179422","display_name":"Lymph","level":2,"score":0.2531000077724457},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.2526000142097473}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1856673","doi":"https://doi.org/10.3389/fonc.2026.1856673","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1856673","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1856673/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:42908516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42908516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:13682961","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13682961/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:078d2727dfbd40ebb7e15ba673eafe9a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/078d2727dfbd40ebb7e15ba673eafe9a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1856673","doi":"https://doi.org/10.3389/fonc.2026.1856673","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1856673","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1856673/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220855780.pdf","grobid_xml":"https://content.openalex.org/works/W7220855780.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W2552099557","https://openalex.org/W2763875663","https://openalex.org/W2802776309","https://openalex.org/W2807857589","https://openalex.org/W3047973464","https://openalex.org/W3158094837","https://openalex.org/W3207557929","https://openalex.org/W4200357248","https://openalex.org/W4211005384","https://openalex.org/W4283029993","https://openalex.org/W4283796995","https://openalex.org/W4291954795","https://openalex.org/W4296904106","https://openalex.org/W4360999313","https://openalex.org/W4366201442","https://openalex.org/W4379646084","https://openalex.org/W4384923167","https://openalex.org/W4387910153","https://openalex.org/W4388345058","https://openalex.org/W4388586358","https://openalex.org/W4388870712","https://openalex.org/W4401032153","https://openalex.org/W4402015521","https://openalex.org/W4409190748","https://openalex.org/W4411107139","https://openalex.org/W4417360319","https://openalex.org/W7125981927"],"related_works":["https://openalex.org/W2810688799","https://openalex.org/W3012234284","https://openalex.org/W3189331974","https://openalex.org/W3109881382","https://openalex.org/W3133584322","https://openalex.org/W2623133919","https://openalex.org/W4323050407","https://openalex.org/W3100542416","https://openalex.org/W3031083751","https://openalex.org/W4407638478"],"abstract_inverted_index":{"Hormone":[0],"receptor-positive,":[1],"human":[2],"epidermal":[3],"growth":[4],"factor":[5],"receptor":[6,46],"2-low":[7],"(HER2-low)":[8],"metastatic":[9,84],"breast":[10,19],"cancer":[11],"(MBC)":[12],"constitutes":[13],"the":[14,98,112],"predominant":[15],"subtype":[16],"of":[17,83,114],"advanced":[18],"cancer,":[20],"with":[21,44,119],"most":[22],"patients":[23],"eventually":[24],"developing":[25],"resistance":[26],"to":[27,67,122],"endocrine":[28],"therapy":[29],"(ET)":[30],"and":[31,53,61,89],"cyclin-dependent":[32],"kinase":[33],"4/6":[34],"inhibitors":[35],"(CDK4/6i).":[36],"This":[37],"case":[38],"report":[39],"describes":[40],"a":[41,59],"64-year-old":[42],"woman":[43],"hormone":[45],"(HR)-positive,":[47],"HER2-low":[48],"MBC":[49],"involving":[50],"lung,":[51],"pleural,":[52],"lymph":[54],"node":[55],"metastases":[56],"who":[57],"achieved":[58],"remarkable":[60],"sustained":[62],"radiographic":[63],"complete":[64],"response":[65],"(rCR)":[66],"palbociclib":[68],"plus":[69],"fulvestrant,":[70],"followed":[71],"by":[72],"letrozole":[73],"after":[74],"fulvestrant":[75],"injection":[76],"intolerance.":[77],"The":[78,107],"patient":[79],"exhibited":[80],"near-complete":[81],"regression":[82],"lesions":[85],"within":[86],"18":[87],"months":[88],"maintained":[90],"remission":[91,109],"for":[92],"over":[93],"6":[94],"years,":[95],"far":[96],"exceeding":[97],"typical":[99],"median":[100],"progression-free":[101],"survival":[102],"observed":[103,110],"in":[104],"clinical":[105],"trials.":[106],"prolonged":[108],"underscores":[111],"existence":[113],"biologically":[115],"distinct":[116],"tumor":[117],"subsets":[118],"exceptional":[120],"sensitivity":[121],"CDK4/6":[123],"inhibition,":[124],"warranting":[125],"investigation":[126],"into":[127],"underlying":[128],"molecular":[129],"mechanisms.":[130]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-08T00:00:00"}